Subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist vs placebo/no treatment
Miscarriage · women trying to conceive by intrauterine insemination
It is very uncertain whether subcutaneous (Sc) gonadotropin‐releasing hormone (GnRH) agonist changes miscarriage rate compared with placebo/no treatment (very low certainty).
1 finding from 1 review
- Luteal phase support for women trying to conceive by intrauterine insemination or sexual intercourse 2022 · Cochrane Headline outcomes onlyRR 0.73 [0.26, 2.1]2 studies · 79 participantsVery low